SUBSCRIBE
SUBSCRIBE

Alexion

NEWS
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
Evaluation: 7 Biopharma Companies’ Market Value Based on Pipelines
July 14, 2016
 · 
3 min read
Genetown
Alexion’s Incredible Run Looks Far From Done
August 19, 2015
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Deals
Alexion, BioMarin, Sanofi, Shire May Be Eyeing Dyax Corp. and Its Rare Genetic Disorder Drug
June 11, 2015
 · 
2 min read
Job Trends
200 Jobs Promised at Alexion Amid €450 Million Expansion
May 11, 2015
 · 
6 min read
Genetown
Alexion Investors May (In Time) Love Lofty Biotech Bid
May 7, 2015
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Alexion Plunks Down $8.4 Billion for Synageva BioPharma, As Dealmaking Roars
May 6, 2015
 · 
6 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
With Alexion Deal in Hand, Blueprint Medicines Preps for $100 Million IPO
March 24, 2015
 · 
4 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Pharm Country
Strong Earnings Could Mean Buying Spree For Alexion Pharmaceuticals Inc., Says Analyst
October 24, 2014
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Booming Alexion Pharmaceuticals Inc. Eyes European Headquarters In Zurich On Expansion Push
October 15, 2014
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Genetown
Alexion to Present at the Leerink Partners Roundtable Series: Rare Disease & Oncology
September 25, 2018
 · 
1 min read
Drug Development
Alexion Announces Successful Phase 3 PREVENT Study of Soliris® (Eculizumab) in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
September 24, 2018
 · 
17 min read
Drug Development
Tarveda Therapeutics Appoints Jeffrey Bloss, M.D. as Chief Medical Officer
September 12, 2018
 · 
6 min read
Genetown
Alexion to Present at Morgan Stanley’s 16th Annual Global Healthcare Conference
September 7, 2018
 · 
1 min read
Genetown
Alexion to Present at Citi’s 13th Annual Biotech Conference
August 29, 2018
 · 
1 min read
Business
GBT Appoints Heidi L. Wagner as Senior Vice President, Government Affairs and Policy
August 21, 2018
 · 
6 min read
FDA
FDA Accepts Priority Review of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the US
August 20, 2018
 · 
14 min read
Drug Development
Alexion Reports Second Quarter 2018 Results
July 26, 2018
 · 
14 min read
Business
Cardurion Pharmaceuticals Appoints Rebecca Frey as Chief Operating Officer
July 24, 2018
 · 
4 min read
Deals
Free Technical Research Reports on Biotech Stocks -- Alkermes, Alnylam Pharma, Altimmune, and Alexion Pharma
July 24, 2018
 · 
7 min read
Load More